References
- Dantoft TM, Andersson L, Nordin S, Skovbjerg S. Chemical intolerance. CRR. 2015;11(2):167–184.
- Nethercott JR, Lee Davidoff L, Curbow B, et al. Multiple chemical sensitivities syndrome: toward a working case definition. Arch Environ Health. 1993;48(1):19–26.
- Bartha L. Multiple chemical sensitivity: a 1999 consensus. Arch Environ Health. 1999;54:147–149.
- Johansson Å, Millqvist E, Nordin S, et al. Relationship between self-reported odor intolerance and sensitivity to inhaled capsaicin: proposed definition of airway sensory hyperreactivity and estimation of its prevalence. Chest. 2006;129(6):1623–1628.
- Nordin S, Millqvist E, LöWhagen O, et al. A short chemical sensitivity scale for assessment of airway sensory hyperreactivity. Int Arch Occup Environ Health. 2004;77(4):249–254.
- Berg ND, Linneberg A, Dirksen A, et al. Prevalence of self-reported symptoms and consequences related to inhalation of airborne chemicals in a Danish general population. Int Arch Occup Environ Health. 2008;81(7):881–887.
- Caress SM, Steinemann AC. A review of a two-phase population study of multiple chemical sensitivities. Environ Health Perspect. 2003;111(12):1490.
- Johansson A, Bramerson A, Millqvist E, et al. Prevalence and risk factors for self-reported odour intolerance: the Skövde population-based study. Int Arch Occup Environ Health. 2005;78(7):559–564.
- Hausteiner C, Bornschein S, Hansen J, et al. Self-reported chemical sensitivity in Germany: a population-based survey. Int J Hyg Environ Health.. 2005;208(4):271–278.
- Hojo S, Ishikawa S, Kumano H, et al. Clinical characteristics of physician-diagnosed patients with multiple chemical sensitivity in Japan. Int J Hyg Environ Health. 2008;211(5-6):682–689.
- Kreutzer R, Neutra RR, Lashuay N. Prevalence of people reporting sensitivities to chemicals in a population based survey. Am J Epidemiol. 1999;150(1):1–12.
- Karvala K, Sainio M, Palmquist E, et al. Prevalence of various environmental intolerances in a Swedish and Finnish general population. Environ Res. 2018;161:220–228.
- Söderholm A, Söderberg A, Nordin S. The experience of living with sensory hyperreactivity—accessibility, financial security, and social relationships. Health Care Women Int. 2011;32(8):686–707.
- Lipson JG. Multiple chemical sensitivities: stigma and social experiences. Med Anthropol Q. 2004;18(2):200–213.
- Gibson DPR, Cheavens J, Warren ML. Chemical sensitivity/chemical injury and life disruption. Women Ther. 1996;19(2):63–79.
- Skovbjerg S, Brorson S, Rasmussen A, et al. Impact of self-reported multiple chemical sensitivity on everyday life: a qualitative study. Scand J Public Health. 2009;37(6):621–626.
- Gibson PR. Of the world but not in it: barriers to community access and education for persons with environmental sensitivities. Health Care Women Int. 2009;31(1):3–16.
- Gibson PR, Sledd LG, McEnroe WH, et al. Isolation and lack of access in multiple chemical sensitivity: a qualitative study. Nurs Health Sci. 2011;13(3):232–237.
- Gibson PR, Placek E, Lane J, et al. Disability-induced identity changes in persons with multiple chemical sensitivity. Qual Health Res. 2005;15(4):502–524.
- Larsson C, Mårtensson L. Experiences of problems in individuals with hypersensitivity to odours and chemicals. J Clin Nurs. 2009;18(5):737–744.
- Gibson PR, Leaf B, Komisarcik V. Unmet medical care needs in persons with multiple chemical sensitivity: a grounded theory of contested illness. JNEP. 2016;6(5):75.
- Skovbjerg S, Johansen JD, Rasmussen A, et al. General practitioners’ experiences with provision of healthcare to patients with self-reported multiple chemical sensitivity. Scand J Prim Health Care. 2009;27(3):148–152.
- Socialstyrelsen. Klassifikation av funktionstillstånd, funktionshinder och hälsa. Stockholm: Socialstyrelsen (Swedish National Board of Health and Welfare); 2003.
- Engel GL. The need for a new medical model: a challenge for biomedicine. Science. 1977;196(4286):129–136.
- Stier-Jarmer M, Grill E, Ewert T, et al. ICF Core Set for patients with neurological conditions in early post-acute rehabilitation facilities. Disabil Rehabil. 2005;27(7–8):389–395.
- Stucki A, Stoll T, Cieza A, et al. ICF Core Sets for obstructive pulmonary diseases. J Rehabil Med. 2004;36(44 Suppl):114–120.
- Cieza A, Chatterji S, Andersen C, et al. ICF Core Sets for depression. J Rehabil Med. 2004;36(44 Suppl):128–134.
- Cieza A, Stucki G, Weigl M, et al. ICF Core Sets for low back pain. J Rehabil Med. 2004;36(44 Suppl):69–74.
- Devoogdt N, Van Kampen M, Geraerts I, et al. Lymphoedema Functioning, Disability and Health questionnaire (Lymph-ICF): reliability and validity. Phys Ther. 2011;91(6):944–957.
- Post MW, de Witte LP, Reichrath E, et al. Development and validation of IMPACT-S, an ICF-based questionnaire to measure activities and participation. J Rehabil Med. 2008;40(8):620–627.
- Rogers S, Forgie S, Lowe D, et al. Development of the International Classification of Functioning, Disability and Health as a brief head and neck cancer patient questionnaire. Int J Oral Maxillofac Surg. 2010;39(10):975–982.
- Streiner DL, Norman GR. Health measurement scales: a practical guide to their development and use. Oxford (UK): Oxford University Press; 2003.
- Nevo B. Face validity revisited. J Educ Meas. 1985;22(4):287–293.
- Nordin S, Palmquist E, Bende M, et al. Normative data for the chemical sensitivity scale for sensory hyperreactivity: the Västerbotten environmental health study. Int Arch Occup Environ Health.. 2013;86(7):749–753.
- Jakobsson U, Westergren A. Statistical methods for assessing agreement for ordinal data. Scand J Caring Sci. 2005;19(4):427–431.
- Altman DG. Practical statistics for medical research. London (UK): Chapman & Hall; 1991. p. 404.
- Byrt T, Bishop J, Carlin JB. Bias, prevalence and kappa. J Clin Epidemiol. 1993;46(5):423–429.